Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
Condition(s):Metastatic Breast CancerLast Updated:July 20, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast CancerLast Updated:July 20, 2018Terminated
Condition(s):Metastatic Breast CancerLast Updated:October 30, 2023Active, not recruiting
Condition(s):Carcinoma, Non-Small-Cell Lung; Secondary; Advanced Stage IIIB; High Thymidylate Synthase ExpressionLast Updated:January 16, 2018Terminated
Condition(s):Breast CancerLast Updated:April 9, 2013Completed
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:January 28, 2016Unknown status
Condition(s):Metastatic Breast CancerLast Updated:October 13, 2023Not yet recruiting
Condition(s):Carcinoma, Non-Small-Cell Lung; Carcinoma BreastLast Updated:November 2, 2022Not yet recruiting
Condition(s):Stage IV (Metastatic) Breast CancerLast Updated:November 26, 2019Terminated
Condition(s):Non Small Cell Lung CarcinomaLast Updated:August 4, 2014Completed
Condition(s):Breast Cancer; Chemotherapy Effect; Disease-free SurvivalLast Updated:February 6, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.